International Journal of Proteomics

Review Article

Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors

Liver cancer serum biomarkers identified after MS-based studies.


Putative liver cancer biomarker	Expression in liver ca sera	References

Complement c3	Increased	[55]
Histidine rich glycoprotein	Increased	[55]
CD14	Increased	[55]
Hepatocyte growth factor	Increased	[55]
C-terminal part of vitronectin V10 fragment	Increased	[56]
Protein complement C3a	Increased	[57]
Annexin VI isoform	Increased	[58]
Complement component 9	Increased	[58]
Ceruloplasmin	Increased	[55, 58]
Serum amyloid A4	Increased	[58]
Serum amyloid A2	Increased	[58]
Serum amyloid A1 isoform 2	Increased	[58]
Cystatin C	Increased	[59]
Neutrophil-activating peptide 2	Increased	[60]
Thrombin light chain	Increased	[61]
Growth-related oncogene alpha (GRO-alpha)	Increased	[61]
Alpha-1 acid glycoprotein	Increased	[62]
Haptoglobin	Increased	[63]
N terminus complement C3f	Decreased	[64]
Fibrinopeptide	Decreased	[64]
Complement C4 alpha peptides	Increased	[64]
Zyxin peptide	Increased	[64]
Coagulation factor XIII peptide	Increased	[64]
Biliverdin diglucuronide	Increased	[64]
Heat-shock protein 27	Increased	[65]
MYH2 protein	Increased	[66]
Mitochondrial ATP synthase	Increased	[66]
Sulphated glycoprotein-2	Increased	[66]
Glial fibrillary acidic protein	Increased	[66]